EX-99.01 2 ex99_01tables.htm EX#99.01 FINANCIAL TABLES EX#99.01 Financial Tables



For Release January 27, 2005
5:00 p.m. EDT
                                                      Contacts:
                              Media: Nancy Ledford
           423-229-5264 / nledford@eastman.com
 
Investors: Greg Riddle
423-229-8692 / griddle@eastman.com



Eastman Announces Fourth-Quarter, Year-End 2004 Financial Results

KINGSPORT, Tenn., Jan. 27, 2005 - Eastman Chemical Company (NYSE:EMN) today announced earnings of $0.68 per diluted share for fourth quarter 2004 versus earnings of $0.13 per diluted share for fourth quarter 2003. Included in the results for fourth quarter 2004 was an income tax benefit of $26 million resulting primarily from the favorable resolution of a prior year’s capital loss carryback refund claim. Excluding the items described in the following paragraph for both periods, fourth-quarter 2004 earnings per diluted share were $0.69, while fourth-quarter 2003 earnings were $0.13 per diluted share. For reconciliation to reported earnings, see Table 8 in the accompanying fourth-quarter and full-year 2004 financial tables.

Included in the results for fourth quarter 2004 were asset impairments and restructuring charges of $18 million and other operating income of $7 million from the previously announced sale of Ariel Research Corporation. Fourth-quarter 2003 results included asset impairments and restructuring charges of $9 million and other operating income of $13 million. For additional information, see “Asset Impairments and Restructuring Charges and Net Deferred Tax Benefits” below.
 

(In millions, except per share amounts)
4Q2004
4Q2003
FY2004
FY2003
Sales revenue
$1,658
$1,434
$6,580
$5,800
Sales revenue excluding restructured, divested and consolidated CASPI product lines*
$1,658
$1,264
$6,139
$5,081
Earnings (Loss) per diluted share
$0.68
$0.13
$2.18
$(3.50)
Earnings per diluted share excluding asset impairments and restructuring charges, other operating income and a net deferred tax benefit*
$0.69
$0.13
$2.82
$1.08
Net cash provided by operating activities
$193
$198
$494
$244

*For reconciliation to reported sales revenue and earnings per diluted share, see Tables 4a and 8 respectively in the accompanying fourth-quarter and full-year 2004 financial tables.  Also see “Asset Impairments and Restructuring Charges and Net Deferred Tax Benefits” for additional information.

“Our full-year 2004 results clearly demonstrate the significant progress we have made improving the company’s profitability,” said Brian Ferguson, chairman and CEO. “However, the continuous escalation of raw material and energy costs throughout 2004, with particular volatility in the fourth quarter, reconfirms pricing as a key determinant of our ability to improve margins.”

Operating earnings in fourth quarter 2004 were $46 million compared with operating earnings in fourth quarter 2003 of $39 million. Excluding asset impairments and restructuring charges and other operating income in both periods, operating earnings were $57 million in fourth quarter 2004 compared with $35 million in fourth quarter 2003. The year-over-year improvement was attributed primarily to a continued focus on more profitable businesses and product lines, cost reduction efforts, higher selling prices and higher sales volume. In fourth quarter 2004, raw material and energy costs increased by approximately $250 million compared with fourth quarter 2003 raw material and energy costs.

Sales revenue for fourth quarter 2004 was $1.66 billion, a 16 percent increase over fourth quarter 2003. The increase in sales revenue was attributed primarily to higher selling prices, especially in the polymers and the performance chemicals and intermediates segments. Fourth-quarter 2003 sales revenue included sales revenue from restructured, divested and consolidated product lines in the coatings, adhesives, specialty polymers and inks (CASPI) segment. Excluding sales from those product lines for fourth quarter 2003, year-over-year sales revenue increased by 31 percent and sales volume increased by 12 percent.

Division and Segment Results 4th Quarter 2004 versus 4th Quarter 2003

Eastman Division’s fourth-quarter 2004 external sales revenue increased by 2 percent compared with fourth quarter 2003 as a result of higher selling prices that offset lower sales volume. Fourth-quarter 2003 results included sales revenue from restructured, divested and consolidated product lines in the CASPI segment. Excluding sales from those product lines for fourth quarter 2003, the division’s sales revenue increased by 30 percent and sales volume increased by 20 percent. For reconciliation to reported sales revenue, see Table 4b in the accompanying fourth-quarter and full-year 2004 financial tables.

Fourth-quarter 2004 operating earnings for Eastman Division were $28 million compared with operating earnings of $16 million in fourth quarter 2003. Fourth-quarter 2004 operating earnings included asset impairments and restructuring charges of $3 million. Fourth-quarter 2003 operating earnings included asset impairments and restructuring charges of $7 million and other operating income of $13 million. Excluding those items for both periods, operating earnings increased as a continued focus on more profitable businesses and product lines, increased sales volume, higher selling prices and cost reduction efforts more than offset higher raw material and energy costs.

Coatings, Adhesives, Specialty Polymers and Inks - The segment’s fourth-quarter external sales revenue declined by 31 percent, primarily the result of the divestiture of certain businesses and product lines in third quarter 2004. Sales revenue for continuing product lines in the segment increased by 18 percent, primarily attributed to an increase in sales volume of 10 percent and higher selling prices. The increase in sales volume resulted primarily from strong demand in end-markets, including the building and construction, and nonwoven markets.

Fourth-quarter 2004 CASPI segment operating earnings included asset impairments and restructuring charges of $2 million, while fourth-quarter 2003 operating earnings included asset impairments and restructuring charges of $7 million and other operating income of $13 million. Excluding those items for both periods, operating earnings increased as a continued focus on more profitable businesses and product lines, increased sales volume and higher selling prices more than offset higher raw material and energy costs.

Performance Chemicals and Intermediates - External sales revenue increased by 47 percent as a result of increased sales volume and higher selling prices. The increased sales volume, primarily in the intermediates businesses and product lines, was attributed to long-term supply arrangements with key customers, improved end-market demand attributable to strong economic growth and increased production capacity. Operating earnings improved substantially as increased sales volume, higher selling prices and continued cost reduction efforts more than offset higher raw material and energy costs.

Specialty Plastics - External sales revenue increased by 19 percent, attributed primarily to higher sales volume. The higher sales volume resulted mainly from continued strong demand for products in new applications, including packaging, opthamalics and housewares. Operating earnings declined substantially, primarily attributed to selling prices not rising as quickly as rapidly increasing raw material and energy costs, particularly for paraxylene, and costs associated with a planned maintenance shutdown at the Kingsport, Tenn., site’s specialty polymers facilities.

Voridian Division’s fourth-quarter 2004 external sales revenue increased by 32 percent due to higher selling prices and increased sales volume. Operating earnings increased year-over-year due primarily to increased sales volume, higher selling prices and cost reduction efforts that more than offset higher raw material and energy costs.

Polymers - External sales revenue increased by 36 percent primarily due to higher selling prices. The increased selling prices were mainly the result of efforts to offset rapidly increasing raw material and energy costs, particularly paraxylene and ethylene glycol. Operating earnings increased as higher selling prices, cost reduction efforts and improved conditions in the polyethylene market more than offset higher raw material and energy costs.

Fibers - External sales revenue increased by 21 percent as a result of improved product mix and increased sales volume. The improved product mix resulted primarily from increased sales volume for acetyl chemicals in the U.S. and for acetate tow in Asia. Operating earnings increased as higher sales volume and improved product mix more than offset higher raw material and energy costs.

Developing Businesses Division’s external sales revenue for fourth quarter 2004 was $29 million compared with $19 million for fourth quarter 2003. Included in fourth-quarter operating results were asset impairments and restructuring charges of $15 million primarily due to the previously announced restructuring of Cendian Corporation and a gain of $7 million from the previously announced sale of Ariel Research Corporation. Excluding those items, operating results declined year-over-year as a result of increased spending for growth initiatives.


Corporate Full-Year 2004 versus Full-Year 2003

Eastman reported earnings of $2.18 per diluted share for full-year 2004 compared with a loss of $3.50 per diluted share for full-year 2003. Included in the results for 2004 was an income tax benefit of $26 million resulting primarily from the favorable resolution of a prior year’s capital loss carryback refund claim. Excluding the items described in the following paragraph for both periods, earnings per diluted share for full year 2004 were $2.82, while full-year 2003 earnings per diluted share were $1.08. For reconciliation to reported results, see Table 8 in the accompanying fourth-quarter and full-year 2004 financial tables.

Included in the results for full-year 2004 were asset impairments and restructuring changes of $206 million ($151 million, net of tax), a net deferred tax benefit of $90 million and other operating income of $7 million ($11 million, net of tax). Full-year 2003 results included asset impairments and restructuring charges of $489 million ($342 million, net of tax), goodwill impairments of $34 million ($34 million, net of tax), other operating income of $33 million ($20 million, net of tax) and the cumulative effect of a change in accounting principle of $3 million ($3 million, net of tax).

Operating earnings for full-year 2004 were $175 million compared with an operating loss of $267 million for full-year 2003. Full-year 2004 operating earnings included asset impairments and restructuring charges of $206 million and other operating income of $7 million. Operating results for full-year 2003 included asset impairments and restructuring charges of $489 million, goodwill impairments of $34 million and other operating income of $33 million. Excluding those items for both periods, operating earnings increased as a continued focus on more profitable businesses and product lines, increased sales volume, cost reduction efforts and higher selling prices more than offset higher raw material and energy costs. In 2004, raw material and energy costs increased by approximately $600 million compared with full-year 2003 raw material and energy costs.

Eastman’s full-year 2004 sales revenue was $6.6 billion, a 13 percent increase compared with full-year 2003. The increase was attributed primarily to higher selling prices and increased sales volume. Excluding sales from the restructured, divested and consolidated product lines in the CASPI segment for both periods, sales revenue and sales volume increased by 21 percent and 11 percent respectively in 2004 compared with 2003.

Division and Segment Results Full-Year 2004 versus Full-Year 2003

Eastman Division’s 2004 external sales revenue increased by 6 percent compared with 2003, primarily the result of increased selling prices and a favorable foreign currency exchange rate. Excluding sales from restructured, divested and consolidated product lines in the CASPI segment for both 2004 and 2003, sales revenue and sales volume increased by 18 percent and 12 percent respectively. For reconciliation to reported sales revenue, see Table 4b in the accompanying fourth-quarter and full-year 2004 financial tables. The division’s 2004 operating earnings were $96 million compared with an operating loss of $384 million in 2003. Operating earnings in 2004 included asset impairments and restructuring charges of $172 million. Operating results for 2003 included asset impairments and restructuring charges of $486 million, goodwill impairments of $34 million and other operating income of $33 million. Excluding those items for both periods, operating earnings improved as an increased focus on more profitable businesses and product lines, increased sales volume, higher selling prices and cost reduction efforts more than offset higher raw material and energy costs.

Coatings, Adhesives, Specialty Polymers and Inks - External sales revenue declined by 8 percent primarily due to lower sales volume. Excluding sales from the restructured, divested and consolidated product lines for both periods, sales revenue and sales volume increased by 15 percent and 11 percent respectively in 2004 compared with 2003. The increased sales volume for continuing products was due primarily to improved end-market demand attributable to strong economic growth and the marketing of new applications for existing products. Operating earnings for the segment were $67 million in 2004 compared with an operating loss of $402 million in 2003. In 2004, operating earnings included asset impairments and restructuring charges of $81 million, while 2003 results included asset impairments and restructuring charges of $428 million, goodwill impairments of $34 million and other operating income of $13 million. Excluding those items for both periods, operating results improved in 2004 compared with 2003, attributed primarily to a continued focus on more profitable businesses and product lines, increased sales volume and cost reduction efforts that more than offset higher raw material and energy costs. For reconciliation to reported sales revenue and operating earnings, see Table 5 in the accompanying fourth-quarter and full-year 2004 financial tables.

Performance Chemicals and Intermediates - External sales revenue increased by 23 percent, primarily the result of increased sales volume and higher selling prices. The increased sales volume was attributed to improved end-market demand due to strong economic growth and the implementation of long-term supply arrangements with key customers. Operating earnings for 2004 included asset impairments and restructuring charges of $38 million, while 2003 operating earnings included asset impairments and restructuring charges of $57 million. Excluding those items for both periods, operating earnings increased as higher sales volume, higher selling prices and cost reduction efforts more than offset higher raw material and energy costs.

Specialty Plastics - External sales revenue increased 15 percent, mainly resulting from higher sales volume. The higher sales volume was attributed primarily to strong demand for products in both new and existing applications. Operating earnings in 2004 included asset impairments and restructuring charges of $53 million, while 2003 operating earnings included asset impairments and restructuring charges of $1 million and other operating income of $20 million. Excluding those items for both periods, operating earnings increased as higher sales volume, continued focus on more profitable businesses and product lines, and cost reduction efforts offset higher raw material and energy costs.

Voridian Division’s full-year 2004 external sales revenue increased by 22 percent, attributed to increased sales volume and higher selling prices. Operating earnings in 2004 were $171 million compared with $187 million in 2003. Included in 2004 operating earnings were asset impairments and restructuring charges of $13 million, while 2003 operating earnings included $3 million of asset impairments and restructuring charges. Excluding those items for both periods, operating earnings declined slightly as increased sales volume, higher selling prices and cost reduction efforts were offset by higher raw material and energy costs. In addition, 2003 operating earnings included a $14 million gain from an insurance settlement related to operational disruptions in 2002.

Polymers - External sales revenue increased by 24 percent primarily due to higher selling prices and increased sales volume. The increased sales volume was mainly the result of continued strong end-market demand attributable in part to increased substitution of PET polymers for other materials. Operating earnings for 2004 were $25 million compared with $62 million for 2003. The 2004 operating earnings included asset impairments and restructuring charges of $13 million, while 2003 operating earnings included asset impairments and restructuring charges of $2 million. Excluding those charges for both periods, operating earnings declined as increased sales volume and higher selling prices were more than offset by higher raw material and energy costs. In addition, 2003 operating earnings included a $14 million gain from an insurance settlement related to previously announced operational disruptions.

Fibers - External sales revenue increased by 15 percent due mainly to increased sales volume, particularly for acetyl chemicals in the U.S. and acetate tow in Asia. Operating earnings increased primarily as a result of the increased sales volume.

Developing Businesses Division’s external sales revenue for 2004 was $121 million compared with $69 million for 2003. Operating results for 2004 included asset impairments and restructuring charges of $21 million primarily due to the previously announced restructuring of Cendian Corporation and other operating income of $7 million from the previously announced sale of Ariel Research Corporation. Excluding those items, operating results declined as a result of increased spending for growth initiatives, partially offset by reduced operating losses associated with the restructuring of Cendian Corporation.

Asset Impairments and Restructuring Charges and Net Deferred Tax Benefits
 
During fourth quarter 2004, Eastman recognized pretax asset impairments and restructuring charges of $18 million. Included in those charges were non-cash asset impairments of $9 million and restructuring charges of $9 million. The non-cash asset impairments related to the adjustment to fair value of assets at Cendian Corporation, impacting the Developing Businesses segment, as a result of a recent decision to shut down Cendian logistics activities. In addition, the company recognized restructuring charges of $9 million primarily related to expected severance.
 
During fourth quarter 2004, Eastman also completed the previously announced sale of Ariel Corporation that resulted in a pretax gain of $7 million.

Cash Flow

Eastman generated $494 million in cash from operations in 2004 versus $244 million in 2003. Contributions to the company’s U.S. defined benefit plans were $3 million in 2004 and $238 million in 2003. Net debt, defined as total borrowings less cash and cash equivalents, declined $298 million in 2004.

Outlook

Commenting on the outlook for first quarter 2005, Ferguson said: “We expect sales volume to remain strong throughout the company, but we also anticipate that key raw material and energy costs will escalate during the quarter. In addition, we expect to implement selling price increases in order to recover our margin over raw material and energy costs. As a result, we expect first-quarter 2005 earnings per share to be similar to the current First Call mean estimate of $0.83 per share. However, volatile raw material and energy costs limit the precision of our estimate.”




Eastman will host a conference call with industry analysts on Jan. 28 at 8:00 a.m. EST. To listen to the live webcast of the conference call, go to www.eastman.com, investors, event information, audio archives. To listen via telephone, the dial-in number is 913-981-5571, passcode number 409787. A telephone replay will be available continuously from 11:00 a.m. EST, Jan. 28, to 12:00 a.m. EST, Feb. 4, 2005, at 888-203-1112, passcode number 409787.

Headquartered in Kingsport, Tenn., Eastman manufactures and markets chemicals, fibers and plastics worldwide. The company has approximately 12,000 employees and had 2004 sales of US$6.6 billion. To learn more about Eastman and its products, visit www.eastman.com 

##

Forward Looking Statements: This news release includes forward-looking statements concerning current expectations for future economic and business conditions; raw material and energy costs; company strategies, actions and efforts to control and reduce costs and to increase overall selling prices and improve financial performance; and overall selling prices, sales volume, raw material and energy costs, and earnings for first quarter 2005. Such expectations are based upon certain preliminary information, internal estimates, and management assumptions, expectations and plans, and are subject to a number of risks and uncertainties inherent in projecting future conditions, events, and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions or expectations prove to be inaccurate or are unrealized. Important factors that could cause actual results to differ materially from such expectations are and will be detailed in the company’s filings with the Securities and Exchange Commission, including the Form 10-Q filed for third quarter 2004 and the Form 10-K to be filed for full-year 2004, available on the Eastman web site at www.eastman.com in the Investors, SEC filings section.



EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
   

FINANCIAL INFORMATION
January 27, 2005


For use in the Eastman Chemical Company Conference Call
at 8:00 AM (EDT), January 28, 2005.

Table of Contents

Item
 
Page
     
TABLE 1
Statements of Earnings
1
     
TABLE 2
Other Sales Information
2-3
     
TABLE 3
Operating Earnings (Loss), Asset Impairments and Restructuring Charges and Other Operating Income
4
     
TABLE 4
Eastman Chemical Company and Eastman Division Pro-Forma Sales Revenue Excluding CASPI Restructured, Divested and Consolidated Product Lines
5
     
TABLE 5
CASPI Segment Detail of Sales Revenue, Operating Earnings (Loss) and Asset Impairments and Restructuring Charges
6
     
TABLE 6
Sales Revenue Change - External Sales
7
     
TABLE 7
Percentage Growth in Sales Volume
8-9
     
TABLE 8
Operating Earnings, Net Earnings, and Earnings Per Share Reconciliation
10
     
TABLE 9
Statements of Cash Flows
11
     
TABLE 10
Selected Balance Sheet Items
12

  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 1

TABLE 1 - STATEMENTS OF EARNINGS

   
Fourth Quarter
 
Twelve Months
 
(Dollars in millions, except per share amounts)
 
2004
 
2003
 
2004
 
2003
 
                               
Sales
       
$
1,658
 
$
1,434
       
$
6,580
     
$
5,800
 
Cost of sales
         
1,442
   
1,249
         
5,602
       
4,990
 
Gross profit
         
216
   
185
         
978
       
810
 
                                           
Selling and general administrative expenses
         
121
   
106
         
450
       
414
 
Research and development expenses
         
38
   
44
         
154
       
173
 
Asset impairments and restructuring charges, net
         
18
   
9
         
206
       
489
 
Goodwill impairment
         
--
   
--
         
--
       
34
 
Other operating income
         
(7
)
 
(13
)
       
(7
)
     
(33
)
Operating earnings (loss)
         
46
   
39
         
175
       
(267
)
                                           
Interest expense, net
         
27
   
32
         
115
       
124
 
Other (income) charges, net
         
--
   
(5
)
       
(4
)
     
(10
)
Earnings (loss) before income taxes and cumulative effect of changes in accounting principle
         
19
   
12
         
64
       
(381
)
Provision (benefit) for income taxes
         
(35
)
 
2
         
(106
)
     
(108
)
Earnings (loss) before cumulative effect of changes in accounting principle
         
54
   
10
         
170
       
(273
)
Cumulative effect of changes in accounting principle, net
         
--
   
--
         
--
       
3
 
Net earnings (loss)
       
$
54
 
$
10
       
$
170
     
$
(270
)
                                           
Earnings (loss) per share
                                         
Basic
                                         
Before cumulative effect of changes in
                                         
accounting principle
       
$
0.69
 
$
0.13
       
$
2.20
     
$
(3.54
)
Cumulative effect of changes in accounting principle, net
         
--
   
--
         
--
       
0.04
 
Net earnings (loss) per share
       
$
0.69
 
$
0.13
       
$
2.20
     
$
(3.50
)
                                           
Diluted
                                         
Before cumulative effect of changes in
                                         
accounting principle
       
$
0.68
 
$
0.13
       
$
2.18
     
$
(3.54
)
Cumulative effect of changes in accounting principle, net
         
--
   
--
         
--
       
0.04
 
Net earnings (loss) per share
       
$
0.68
 
$
0.13
       
$
2.18
     
$
(3.50
)
                                           
Shares (in millions) outstanding at end of period
         
79.3
   
77.4
         
79.3
       
77.4
 
                                           
Shares (in millions) used for earnings per share calculation
                                         
Basic
         
78.1
   
77.1
         
77.6
       
77.1
 
Diluted
         
79.2
   
77.5
         
78.3
       
77.1
 
                                           

  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 2

TABLE 2 - OTHER SALES INFORMATION    

 
Fourth Quarter, 2004
(Dollars in millions)
 
External Sales
 
Interdivisional Sales
 
 
Total Sales
Sales by Division and Segment
           
Eastman Division
           
Coatings, Adhesives, Specialty Polymers, and Inks
$
282
$
1
$
283
Performance Chemicals and Intermediates
 
373
 
155
 
528
Specialty Plastics
 
169
 
11
 
180
Total Eastman Division
 
824
 
167
 
991
             
Voridian Division
           
Polymers
 
611
 
19
 
630
Fibers
 
194
 
22
 
216
Total Voridian Division
 
805
 
41
 
846
             
Developing Businesses Division
           
Developing Businesses
 
29
 
98
 
127
Total Developing Businesses Division
 
29
 
98
 
127
             
Total Eastman Chemical Company
$
1,658
$
306
$
1,964
             
 
Fourth Quarter, 2003*
   
External Sales
 
Interdivisional Sales
 
 
Total Sales
Sales by Division and Segment
           
Eastman Division
           
Coatings, Adhesives, Specialty Polymers, and Inks
$
409
$
--
$
409
Performance Chemicals and Intermediates
 
254
 
135
 
389
Specialty Plastics
 
142
 
9
 
151
Total Eastman Division
 
805
 
144
 
949
             
Voridian Division
           
Polymers
 
450
 
14
 
464
Fibers
 
160
 
20
 
180
Total Voridian Division
 
610
 
34
 
644
             
Developing Businesses Division
           
Developing Businesses
 
19
 
100
 
119
Total Developing Businesses Division
 
19
 
100
 
119
             
Total Eastman Chemical Company
$
1,434
$
278
$
1,712
             

* Sales revenues for 2003 have been realigned to reflect certain product movements between the CASPI and PCI segments effective in the first quarter 2004.

  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 3

TABLE 2 - OTHER SALES INFORMATION (Continued)    

 
Twelve Months, 2004
(Dollars in millions)
 
External Sales
 
Interdivisional Sales
 
 
Total Sales
Sales by Division and Segment
           
Eastman Division
           
Coatings, Adhesives, Specialty Polymers, and Inks
$
1,554
$
1
$
1,555
Performance Chemicals and Intermediates
 
1,347
 
583
 
1,930
Specialty Plastics
 
644
 
51
 
695
Total Eastman Division
 
3,545
 
635
 
4,180
             
Voridian Division
           
Polymers
 
2,183
 
69
 
2,252
Fibers
 
731
 
88
 
819
Total Voridian Division
 
2,914
 
157
 
3,071
             
Developing Businesses Division
           
Developing Businesses
 
121
 
424
 
545
Total Developing Businesses Division
 
121
 
424
 
545
             
Total Eastman Chemical Company
$
6,580
$
1,216
$
7,796
             
 
Twelve Months, 2003*
   
External Sales
 
Interdivisional Sales
 
 
Total Sales
Sales by Division and Segment
           
Eastman Division
           
Coatings, Adhesives, Specialty Polymers, and Inks
$
1,683
$
--
$
1,683
Performance Chemicals and Intermediates
 
1,098
 
495
 
1,593
Specialty Plastics
 
559
 
49
 
608
Total Eastman Division
 
3,340
 
544
 
3,884
             
Voridian Division
           
Polymers
 
1,756
 
68
 
1,824
Fibers
 
635
 
80
 
715
Total Voridian Division
 
2,391
 
148
 
2,539
             
Developing Businesses Division
           
Developing Businesses
 
69
 
396
 
465
Total Developing Businesses Division
 
69
 
396
 
465
             
Total Eastman Chemical Company
$
5,800
$
1,088
$
6,888

* Sales revenues for 2003 have been realigned to reflect certain product movements between the CASPI and PCI segments effective in the first quarter 2004.
 
Fourth Quarter
Twelve Months
(Dollars in millions)
 
2004
 
2003
 
2004
 
2003
                 
Sales by Region - External Sales
 
 
 
 
       
United States and Canada 
$
939
$
797
$
3,723
$
3,302
Europe, Middle East, and Africa
 
330
 
335
 
1,467
 
1,368
Asia Pacific
 
223
 
165
 
785
 
643
Latin America
 
166
 
137
 
605
 
487
 
$
1,658
$
1,434
$
6,580
$
5,800


  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 4


TABLE 3 - OPERATING EARNINGS (LOSS), ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES AND OTHER OPERATING INCOME

             
Fourth Quarter
 
Twelve Months
(Dollars in millions)
2004
 
2003**
 
2004
 
2003**
                           
Operating Earnings (Loss) by Segment and Certain Items
             
   
Eastman Division Segments
             
     
Coatings, Adhesives, Specialty Polymers, and Inks
             
           
Operating earnings (loss)
$
23
$
17
$
67
$
(402)
           
Asset impairments and restructuring charges
2
 
7
 
81
 
462
           
Other operating (income)/expense
--
 
(13)
 
--
 
(13)
                           
     
Performance Chemicals and Intermediates
             
           
Operating earnings (loss)
6
 
(11)
 
16
 
(45)
           
Asset impairments and restructuring charges
1
 
--
 
38
 
57
                           
     
Specialty Plastics
             
           
Operating earnings
(1)
 
10
 
13
 
63
           
Asset impairments and restructuring charges
--
 
--
 
53
 
1
           
Other operating (income)
--
 
--
 
--
 
(20)
                           
       
Total operating earnings (loss)
$
28
$
16
$
96
$
(384)
       
Total asset impairments and restructuring charges
$
3
$
7
$
172
$
520
       
Total other operating (income)/expense
$
--
$
(13)
$
--
$
(33)
                   
   
Voridian Division Segments
             
     
Polymers
             
           
Operating earnings
$
14
$
6
$
25
$
62
           
Asset impairments and restructuring charges
--
 
1
 
13
 
2
                           
     
Fibers
             
           
Operating earnings
36
 
30
 
146
 
125
           
Asset impairments and restructuring charges
--
 
1
 
--
 
1
                           
       
Total operating earnings
$
50
$
36
$
171
$
187
       
Total asset impairments and restructuring charges
$
--
$
2
$
13
$
3
                           
   
Developing Business Division Segment
             
     
Developing Businesses
             
           
Operating loss
$
(26)
$
(13)
$
(86)
$
(65)
           
Asset impairments and restructuring charges
15
 
--
 
21
 
--
           
Other operating (income)
(7)
 
--
 
(7)
 
--
                           
       
Total operating loss
$
(26)
$
(13)
$
(86)
$
(65)
       
Total asset impairments and restructuring charges
$
15
$
--
$
21
$
--
       
Total other operating (income)
(7)
 
--
 
(7)
 
--
                       
   
Eliminations to operating earnings
$
(6)
$
--
$
(6)
$
(5)
                       
Total Eastman Chemical Company
             
       
Total operating earnings (loss)
$
46
$
39
$
175
$
(267)
       
Total asset impairments and restructuring charges
$
18
$
9
$
206
$
523
       
Total other operating income
$
(7)
$
(13)
$
(7)
$
(33)

** Operating earnings for 2003 have been realigned to reflect certain product movements between the CASPI and PCI segments effective in the first quarter 2004. 


  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 5

TABLE 4a- EASTMAN CHEMICAL COMPANY DETAIL OF SALES REVENUE

   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2004
 
2004
 
2004
 
2004
 
2004
                     
Sales Revenue
$
1,597
$
1,676
$
1,649
$
1,658
$
6,580
Less: CASPI restructured, divested, and consolidated product lines (1)
 
174
 
193
 
74
 
--
 
441
Sales revenue - continuing product lines
$
1,423
$
1,483
$
1,575
$
1,658
$
6,139
                     


   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2003
 
2003
 
2003
 
2003
 
2003
                     
Sales Revenue
$
1,441
$
1,481
$
1,444
$
1,434
$
5,800
Less: CASPI restructured, divested, and consolidated product lines (1)
 
174
 
190
 
185
 
170
 
719
Sales revenue - continuing product lines
$
1,267
$
1,291
$
1,259
$
1,264
$
5,081
                     

TABLE 4b- EASTMAN DIVISION DETAIL OF SALES REVENUE

   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2004
 
2004
 
2004
 
2004
 
2004
                     
Sales Revenue
$
886
$
943
$
892
$
824
$
3,545
Less: CASPI divested/consolidated product lines (1)
 
174
 
193
 
74
 
--
 
441
Sales revenue - continuing product lines
$
712
$
750
$
818
$ 
824
$
3,104
                     

   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2003
 
2003
 
2003
 
2003
 
2003
                     
Sales Revenue
$
852
$
865
$
818
$
805
$
3,340
Less: CASPI divested/consolidated product lines (1)
 
174
 
190
 
185
 
170
 
719
Sales revenue - continuing product lines
$
678
$
675
$
633
$ 
635
$
2,621
                   

(1) These businesses and product lines include acrylate ester monomers, composites (unsaturated polyester resins), inks and graphic arts raw materials, liquid resins, powder resins and textile chemicals divested on July 31, 2004 as well as other restructuring, divestiture and consolidation activities that the Company has completed related to these businesses and product lines.


  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 6

TABLE 5 - CASPI SEGMENT DETAIL OF SALES REVENUE, OPERATING EARNINGS (LOSS) AND ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES

   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2004
 
2004
 
2004
 
2004
 
2004
                     
Sales Revenue
                   
Sales revenue - CASPI restructured, divested, and consolidated product lines (1)
$
174
$
193
$
74
$
--
$
441
Sales revenue - continuing product lines
 
265
 
283
 
283
 
282
 
1,113
Total sales revenue
$
439
$
476
$
357
$
282
$
1,554
                     
Operating Earnings (Loss) and Asset Impairments and Restructuring Charges
Operating loss - CASPI restructured, divested, and consolidated product lines (1) (2)
$
(11)
$
(72)
$
(2)
$
--
$
(85)
Operating earnings - continuing product lines
 
41
 
48
 
40
 
23
 
152
Total Operating earnings (loss)
$
30
$
(24)
$
38
$
23
$
67
                     
Other Operating (expense)
$
--
$
--
$
--
$
--
$
--
Asset impairments and restructuring charges - CASPI restructured, divested, and consolidated product lines (1)
 
5
 
66
 
1
 
--
 
72
Asset impairments and restructuring charges - continuing product lines
 
1
 
3
 
3
 
2
 
9
Total asset impairments and restructuring charges
$
6
$
69
$
4
$
2
$
81

   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2003
 
2003
 
2003
 
2003
 
2003
                     
Sales Revenue
                   
Sales revenue - CASPI restructured, divested, and consolidated product lines (1)
$
174
$
190
$
185
$
170
$
719
Sales revenue - continuing product lines
 
237
 
251
 
236
 
240
 
964
Total sales revenue
$
411
$
441
$
421
$
410
$
1,683
                     
Operating Earnings (Loss) and Asset Impairments and Restructuring Charges
Operating loss - CASPI restructured, divested, and consolidated product lines (1) (2)
$
(31)
$
(28)
$
(464)
$
(15)
$
(538)
Operating earnings - continuing product lines
 
28
 
47
 
29
 
32
 
136
Total Operating earnings (loss)
$
(3)
$
19
$
(435)
$
17
$
(402)
                     
Other Operating income
$
--
$
--
$
--
$
(13)
$
(13)
Asset impairments and restructuring charges - CASPI restructured, divested, and consolidated product lines (1)
 
1
 
1
 
449
 
6
 
457
Asset impairments and restructuring charges - continuing product lines
 
1
 
--
 
3
 
1
 
5
Total asset impairments and restructuring charges
$
2
$
1
$
452
$
7
$
462

(1) See note (1) to Table 4a and 4b
(2) Includes allocated costs consistent with the Company’s historical practices, some of which may remain and could be reallocated to the remainder of the segment and other segments.

  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 7

TABLE 6 - SALES REVENUE CHANGE - EXTERNAL SALES

 
Fourth Quarter, 2004 Compared to Fourth Quarter, 2003
     
Change in External Sales Revenue Due To
 
 
Revenue
% Change
 
 
Volume Effect
 
 
Price Effect
 
Product
Mix
Effect
 
Exchange
Rate
Effect
                   
Eastman Division
                 
Coatings, Adhesives, Specialty Polymers,
                 
and Inks
(31) %
 
(36) %
 
6 %
 
(2) %
 
1 %
Performance Chemicals and Intermediates
47 %
 
28 %
 
19 %
 
(1) %
 
1 %
Specialty Plastics
19 %
 
15 %
 
2 %
 
-- %
 
2 %
Total Eastman Division
2 %
 
(7) %
 
9 %
 
(1) %
 
1 %
                   
Voridian Division
                 
Polymers
36 %
 
4 %
 
28 %
 
1 %
 
3 %
Fibers
21 %
 
10 %
 
-- %
 
10 %
 
1 %
Total Voridian Division
32 %
 
6 %
 
21 %
 
3 %
 
2 %
                   
Developing Businesses Division
                 
Developing Businesses
49 %
 
-- %
 
-- %
 
49 %
 
-- %
Total Developing Businesses Division
49 %
 
-- %
 
-- %
 
49 %
 
-- %
                   
Total Eastman Chemical Company
16 %
 
(1) %
 
14 %
 
1 %
 
2 %


 
Twelve Months, 2004 Compared to Twelve Months, 2003
     
Change in External Sales Revenue Due To
 
 
Revenue
% Change
 
 
Volume Effect
 
 
Price Effect
 
Product
Mix
Effect
 
Exchange
Rate
Effect
                   
Eastman Division
                 
Coatings, Adhesives, Specialty Polymers,
                 
and Inks
(8) %
 
(11) %
 
2 %
 
(1) %
 
2 %
Performance Chemicals and Intermediates
23 %
 
12 %
 
11 %
 
(1) %
 
1 %
Specialty Plastics
15 %
 
12 %
 
1 %
 
-- %
 
2 %
Total Eastman Division
6 %
 
-- %
 
5 %
 
(1) %
 
2 %
                   
Voridian Division
                 
Polymers
24 %
 
9 %
 
12 %
 
-- %
 
3 %
Fibers
15 %
 
13 %
 
(2) %
 
3 %
 
1 %
Total Voridian Division
22 %
 
10 %
 
8 %
 
1 %
 
3 %
                   
Developing Businesses Division
                 
Developing Businesses
74 %
 
-- %
 
-- %
 
74 %
 
-- %
Total Developing Businesses Division
74 %
 
-- %
 
-- %
 
74 %
 
-- %
                   
Total Eastman Chemical Company
13 %
 
4 %
 
6 %
 
1 %
 
2 %

  
     

 


 
EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 8

TABLE 7 - PERCENTAGE GROWTH IN SALES VOLUME

 
Fourth Quarter, 2004 Compared to
 
Fourth Quarter, 2003
         
Total
 
External
 
Interdivisional
 
Including
 
Volume
 
Volume
 
Interdivisional
           
Eastman Division
 
 
 
 
 
Coatings, Adhesives, Specialty Polymers, and Inks
(34) %
 
-- %
 
(34) %
Performance Chemicals and Intermediates
27 %
 
(2) %
 
15 %
Specialty Plastics
16 %
 
5 %
 
14 %
Total Eastman Division
(2) %
 
(1) %
 
(2) %
           
Voridian Division
         
Polymers
4 %
 
21 %
 
5 %
Fibers
9 %
 
10 %
 
10 %
Total Voridian Division
5 %
 
12 %
 
6 %
           
Developing Businesses Division
         
Developing Businesses
-- %
 
-- %
 
-- %
Total Developing Businesses Division
-- %
 
-- %
 
-- %
           
Total Eastman Chemical Company
1 %
       
           
         
Regional sales volume growth
       
United States and Canada
7 %
     
Europe, Middle East, and Africa
(20) %
     
Asia Pacific
12 %
     
Latin America
(8) %
     

  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 9

TABLE 7 - PERCENTAGE GROWTH IN SALES VOLUME (Continued)

 
Twelve Months, 2004 Compared to
 
Twelve Months, 2003
         
Total
 
External
 
Interdivisional
 
Including
 
Volume
 
Volume
 
Interdivisional
           
Eastman Division
 
 
 
 
 
Coatings, Adhesives, Specialty Polymers, and Inks
(10) %
 
>100 %
 
(10) %
Performance Chemicals and Intermediates
12 %
 
5 %
 
9 %
Specialty Plastics
12 %
 
(3) %
 
10 %
Total Eastman Division
2 %
 
5 %
 
3 %
           
Voridian Division
         
Polymers
9 %
 
(11) %
 
8 %
Fibers
13 %
 
10 %
 
11 %
Total Voridian Division
10 %
 
6 %
 
9 %
           
Developing Businesses Division
         
Developing Businesses
-- %
 
-- %
 
-- %
Total Developing Businesses Division
-- %
 
-- %
 
-- %
           
Total Eastman Chemical Company
5 %
       
           
         
Regional sales volume growth
       
United States and Canada
7 %
     
Europe, Middle East, and Africa
(4) %
     
Asia Pacific
7 %
     
Latin America
12 %
     

  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 10

TABLE 8 - OPERATING EARNINGS, NET EARNINGS, AND EARNINGS PER SHARE RECONCILIATION

OPERATING EARNINGS, NET EARNINGS, AND NET EARNINGS PER DILUTED SHARE

   
Fourth Quarter 2004
(Dollars in millions)
 
Operating
Earnings
 
Net Earnings
 
Net earnings per diluted share
             
As reported
$
46
$
54
$
0.68
             
Certain Items:
           
Asset impairments and restructuring charges
 
18
 
11
 
0.14
Other operating income
 
(7)
 
(11)
 
(0.13)
Excluding certain items
$
57
$
54
$
0.69

   
Fourth Quarter 2003
(Dollars in millions)
 
Operating
Earnings
 
Net Earnings
 
Net earnings per diluted share
             
As reported
$
39
$
10
$
0.13
             
Certain Items:
           
Asset impairments and restructuring charges
 
9
 
8
 
0.10
Other operating income
 
(13)
 
(8)
 
(0.10)
Excluding certain items
$
35
$
10
$
0.13


   
Twelve Months, 2004
(Dollars in millions)
 
Operating
Earnings
 
Net Earnings
 
Net earnings per diluted share
             
As reported
$
175
$
170
$
2.18
             
Certain Items:
           
Asset impairments and restructuring charges
 
206
 
151
 
1.93
Other operating income
 
(7)
 
(11)
 
(0.14)
Net deferred income tax benefits
 
--
 
(90)
 
(1.15)
Excluding certain items
$
374
$
220
$
2.82

   
Twelve Months, 2003
(Dollars in millions)
 
Operating
Earnings
 
Net Earnings
 
Net earnings per diluted share
             
As reported
$
(267)
$
(270)
$
(3.50)
             
Certain Items:
           
Asset impairments and restructuring charges
 
523
 
376
 
4.88
Other operating income
 
(33)
 
(20)
 
(0.26)
Cumulative effect of a change in accounting principle
     
(3)
 
(0.04)
Excluding certain items
$
223
$
83
$
1.08


  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 11

TABLE 9 - STATEMENTS OF CASH FLOWS

   
Twelve Months
(Dollars in millions)
 
2004
 
2003
         
Cash flows from operating activities
       
Net earnings (loss)
$
170
$
(270)
 
       
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
       
Depreciation and amortization
 
322
 
367
Cumulative effect of changes in accounting principles, net
 
--
 
(3)
Asset impairments
 
141
 
500
Gain on sales of assets
 
(8)
 
(33)
Provision (benefit) for deferred income taxes
 
(136)
 
(140)
Changes in operating assets and liabilities, net of divestitures:
       
Increase in receivables
 
(133)
 
(46)
Decrease in inventories
 
18
 
41
Increase (decrease) in trade payables
 
49
 
(2)
Increase (decrease) in liabilities for employee benefits and incentive pay
 
67
 
(214)
Other items, net
 
4
 
44
         
Net cash provided by operating activities
 
494
 
244
         
Cash flows from investing activities
       
Additions to properties and equipment
 
(248)
 
(230)
Proceeds from sale of assets, net of cash acquired
 
127
 
71
Additions to capitalized software
 
(14)
 
(15)
Acquisitions, net of cash acquired
 
(4)
 
--
Other items, net
 
(9)
 
14
         
Net cash used in investing activities
 
(148)
 
(160)
         
Cash flows from financing activities
       
Net (decrease) in commercial paper, credit facility and other short-term borrowings
 
(19)
 
39
Proceeds from long-term borrowings
 
--
 
495
Repayment of borrowings
 
(500)
 
(5)
Dividends paid to stockholders
 
(137)
 
(136)
Proceeds from stock option exercises
 
77
 
--
Other items
 
--
 
4
         
Net cash provided by (used in) financing activities
 
(579)
 
397
         
Net change in cash and cash equivalents
 
(233)
 
481
         
Cash and cash equivalents at beginning of period
 
558
 
77
         
Cash and cash equivalents at end of period
$
325
$
558


  
     

 


EASTMAN CHEMICAL COMPANY - EMN
January 27, 2005
 
5:30 PM EDT
 
Page 12

TABLE 10 - SELECTED BALANCE SHEET ITEMS

 
December 31,
December 31,
(Dollars in millions)
2004
2003
         
Current Assets
$
1,776
$
2,010
         
Net Properties
 
3,191
 
3,419
         
Other Assets
 
948
 
815
         
Total Assets
$
5,915
$
6,244
         
         
Payables and Other Current Liabilities
$
1,125
$
973
         
Short-term Borrowings
 
1
 
504
         
Long-term Borrowings
 
2,061
 
2,089
         
Other Liabilities
 
1,537
 
1,635
         
Stockholders’ Equity
 
1,191
 
1,043
         
Total Liabilities and Stockholders’ Equity
$
5,915
$
6,244